Penobscot Investment Management Company, Inc. Astrazeneca PLC Transaction History
Penobscot Investment Management Company, Inc.
- $1.27 Billion
- Q3 2025
A detailed history of Penobscot Investment Management Company, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 71,284 shares of AZN stock, worth $5.87 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
71,284
Previous 67,022
6.36%
Holding current value
$5.87 Million
Previous $4.68 Million
16.76%
% of portfolio
0.43%
Previous 0.41%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,449Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...